Results 161 to 170 of about 19,748 (246)

Final analysis of the RESONATE-2 study: up to 10 years of follow-up of first-line ibrutinib treatment for CLL/SLL.

Blood
Burger JA, Barr PM, Robak T, Owen C, Tedeschi A, Sarma A, Patten PEM, Grosicki S, McCarthy H, Offner F, Szafer-Glusman E, Zhou C, Szoke A, Neumayr L, Dean JP, Ghia P, Kipps TJ.   +16 more
europepmc   +1 more source

First-line treatment for CLL in the era of targeted therapy. [PDF]

Blood Cancer J
Davids MS, Stilgenbauer S, Tam CS.
europepmc   +1 more source

ID helix-loop-helix proteins as determinants of cell survival in B-cell chronic lymphocytic leukemia cells in vitro [PDF]

, 2015
Ademokun, JA, Norton, JD, Weiler, S
core   +1 more source

Real-world study on patient characteristics, treatment patterns and outcomes for treated patients with chronic lymphocytic leukemia during 2013-2022 in Finland. [PDF]

Ann Hematol
Ranti J, Jamalzadeh S, Mäkelä E, Vikkula J, Havula E, Luopajärvi S, Lindström V.   +6 more
europepmc   +1 more source

Demographic Characteristics, Survival and Prognostic Factors for Mortality in Cats with Primary Immune-Mediated Hemolytic Anemia [PDF]

Barker, Campbell, Christopher, Cotter, Dunn, Gleich, Jackson, Kohn, Lutz, Meichner, Mitchell, Naik, O'Neill, Ottenjann, Piek, Piek, Piek, Reimer, Roumier, Ruple-Czerniak, Scott, Stockham, Swann, Tasker, Tasker, Vagace, Visco, Wardrop, Weinkle, Weiss, Weiss, Werner   +31 more
core   +1 more source

ATM inhibition decreases ERK activation and is synergistic with ibrutinib in primary chronic lymphocytic leukemia cells. [PDF]

Blood Adv
Kost SEF, Saleh A, Brown J, Yuan SH, Kuzio B, Yang L, Banerji V, Gibson SB, Johnston JB, Katyal S.   +9 more
europepmc   +1 more source

Outcome of adjuvant chemotherapy with lomustine, vinblastine and chlorambucil on management of canine mast cell tumour of high to intermediate risk

, 2018
Rodrigo dos Santos Horta, Gleidice Eunice Lavalle, Mariana Pinto da Costa, Larissa Layara de Moura, A. Marcinowska, R.B. Araújo   +5 more
openalex   +1 more source

Antiproliferative activities of phytochemicals isolated from the leaves of Dolichos kilimandischaricus (Harms) ex Taub. (Fabaceae) on Jurkat and HL-60 leukemic cells. [PDF]

BMC Complement Med Ther
Sithole S, Mushonga P, Heydenreich M, Mawere C, Mukanganyama S.   +4 more
europepmc   +1 more source

Clinical presentation, treatment and outcome in 31 dogs with presumed primary colorectal lymphoma (2001-2013) [PDF]

, 2017
Borrego, J F, Burton, J M, Desmas, I, Di Bella, A, Gauthier, M, Kirstal, O, Kristal, G, Lara-Garcia, A, Post, G   +8 more
core   +1 more source

Acalabrutinib-obinutuzumab improves survival vs chemoimmunotherapy in treatment-naive CLL in the 6-year follow-up of ELEVATE-TN.

Blood
Sharman JP, Egyed M, Jurczak W, Skarbnik A, Patel K, Flinn IW, Kamdar M, Munir T, Walewska R, Hughes M, Fogliatto LM, Herishanu Y, Banerji V, Follows G, Walker P, Ghia P, Janssens A, Byrd JC, Ferrant E, Ferrajoli A, Wierda WG, Wachira CW, Suterwala BT, Miranda P, Munugalavadla V, Wun CC, Woyach JA.   +26 more
europepmc   +1 more source